PCK1 and cancer: Functional studies demonstrated that PCK1 shRNA inhibited cell proliferation (EdU-positive nuclei ratio decrease, Fig. 2K), viability (CCK-8 OD reduction, Fig. 2L), migration, and invasion (“Transwell” assays, results quantified in Fig. 2M) in primary cancer cells.